Home > Insider Trading > Filing (0001415889-21-002621)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697362	Burkes Michael Brophy	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-05-18	10,564	$10.41	99,222	No	4	M	Direct
Common Stock	Acquisiton	2021-05-18	5,035	$9.29	104,257	No	4	M	Direct
Common Stock	Acquisiton	2021-05-18	5,208	$19.68	109,465	No	4	M	Direct
Common Stock	Disposition	2021-05-18	15,240	$93.16	94,225	No	4	S	Direct
Common Stock	Disposition	2021-05-18	5,567	$93.68	88,658	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-05-18	10,564	$0.00	10,564	$10.41
Common Stock	Stock Option (right to buy)	Disposition	2021-05-18	5,035	$0.00	5,035	$9.29
Common Stock	Stock Option (right to buy)	Disposition	2021-05-18	5,208	$0.00	5,208	$19.68

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2027-06-08	No	4	M	Direct
10,070	2028-03-08	No	4	M	Direct
23,959	2029-03-21	No	4	M	Direct

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.51 to $93.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.5150 to $93.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.